Last Updated:
1:37 pm
Thursday, August 14, 2025
Cambium Bio Ltd. engages in the development and commercialization of regenerative therapies derived from novel processed human platelets. The company is headquartered in Paddington, Australia.
asx-cmb
Market Cap
AU$4.02M
Volume
715
Open
0.37
AU$
High
0.37
AU$
Low
0.37
AU$
Shares On Issue
12M
52 Week Low
0.19
AU$
52 Week High
0.68
AU$
Website
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved